Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
698 JPY | +1.75% | +4.49% | +23.10% |
Business Summary
Number of employees: 40
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Discovery
100.0
%
| 976 | 100.0 % | 63 | 100.0 % | -93.54% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
55.5
%
| 950 | 97.4 % | 35 | 55.5 % | -96.32% |
United States
44.5
%
| 26 | 2.6 % | 28 | 44.5 % | +8.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yasuo Urata
FOU | Founder | 68 | 04-03-17 |
Kohei Hata
DFI | Director of Finance/CFO | - | 18-12-31 |
Director/Board Member | 58 | 07-11-30 | |
Comptroller/Controller/Auditor | 73 | 11-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yasuo Urata
FOU | Founder | 68 | 04-03-17 |
Naoko Iino
BRD | Director/Board Member | 63 | 23-02-28 |
Director/Board Member | 58 | 07-11-30 | |
Yasushi Saito
BRD | Director/Board Member | - | 22-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 20,961,600 | 18,715,362 ( 89.28 %) | 88,738 ( 0.4233 %) | 89.28 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ONCOLYS BIOPHARMA INC. 0.41% | 82,200 | 0.41% | 428,529 $ |
Company contact information
Oncolys BioPharma, Inc.
Toranomon Towers Office 4-1-28 Toranomon
105-0001, Tokyo
+
http://www.oncolys.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+23.10% | 92.07M | |
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
+55.45% | 25.43B | |
-14.78% | 15.59B | |
-18.49% | 11.49B | |
-15.61% | 11.1B | |
-44.02% | 11.3B | |
+4.94% | 8.75B |
- Stock Market
- Equities
- 4588 Stock
- Company Oncolys BioPharma Inc.